Tectonic Therapeutic Inc ( (TECX) ) has released its Q4 earnings. Here is a breakdown of the information Tectonic Therapeutic Inc presented to its investors.
Tectonic Therapeutic Inc., based in Watertown, Massachusetts, is a clinical-stage biotechnology company specializing in the development of therapeutic proteins and antibodies targeting G-protein coupled receptors (GPCRs) to address significant unmet medical needs.